VTCN1 antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
VTCN1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab09461
tested applications
ELISA, IHC, WB
Description
Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.
Documents del producto
Product specifications
Category | Primary Antibodies |
Immunogen Target | V-set domain containing T cell activation inhibitor 1 (VTCN1) |
Host | Rabbit |
Reactivity | Human, Mouse, Rat |
Recommended Dilution | WB: 1:200-1:2000; IHC: 1:50-1:200 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 50-80 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, IHC, WB |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | Q7Z7D3 |
Gene ID | 79679 |
Alias | V-set domain-containing T-cell activation inhibitor 1,B7 homolog 4 (B7-H4),B7h.5,Immune costimulatory protein B7-H4,Protein B7S1,T-cell costimulatory molecule B7x,VTCN1,B7H4 |
Background | Antibody anti-VTCN1 |
Status | RUO |
Note | Mol. Weight 50-80 kDa |
Descripción
Related Products

Human VTCN1 (V-set domain-containing T-cell activation inhibitor 1) ELISA Kit
Ver Producto
VTCN1 antibody
Negatively regulates T-cell-mediated immune response by inhibiting T-cell activation, proliferation, cytokine production and development of cytotoxicity. When expressed on the cell surface of tumor macrophages, plays an important role, together with regulatory T-cells(Treg), in the suppression of tumor-associated antigen-specific T-cell immunity. Involved in promoting epithelial cell transformation.
Ver Producto